Curis Inc. (NASDAQ: CRIS) Stock Information | RedChip

Curis Inc. (NASDAQ: CRIS)


$3.3200
+0.2400 ( +2.47% ) 75.7K

Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

Market Data


Open


$3.3200

Previous close


$3.0800

Volume


75.7K

Market cap


$28.44M

Day range


$3.1400 - $3.5350

52 week range


$3.0500 - $17.4900

SEC Filings


Form Type Description Pages Date
8-k 8K-related 16 Nov 14, 2024
10-q Quarterly Reports 63 Nov 14, 2024
8-k 8K-related 30 Oct 30, 2024
10-q Quarterly Reports 62 Aug 01, 2024
8-k 8K-related 15 Aug 01, 2024
4 Insider transactions 1 May 23, 2024
4 Insider transactions 1 May 23, 2024
4 Insider transactions 1 May 23, 2024
4 Insider transactions 1 May 23, 2024
4 Insider transactions 1 May 23, 2024

Latest News